CAMBRIDGE, Mass., Sept. 12, 2024 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO) a biotechnology company innovating genetic medicines for people living with rare and prevalent diseases, announced that Geoff McDonough, M.D., president and chief executive officer, will participate in a fireside chat at the 2024 Cantor Global Healthcare Conference on Thursday, September 19, 2024 at 10:20 a.m. ET in New York. A live webcast of the presentation will be available on the investor section of the co
One of the biggest stories of last week was how Generation Bio Co. ( NASDAQ:GBIO ) shares plunged 21% in the week since...
Generation Bio ( NASDAQ:GBIO ) Second Quarter 2024 Results Key Financial Results Revenue: US$4.09m (up 365% from 2Q...